Cargando…
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469463/ https://www.ncbi.nlm.nih.gov/pubmed/37662957 http://dx.doi.org/10.3389/fimmu.2023.1243241 |
| _version_ | 1785099446518808576 |
|---|---|
| author | Jiménez-Ubieto, Ana Martín-Muñoz, Alejandro Poza, María Dorado, Sara García-Ortiz, Almudena Revilla, Enrique Sarandeses, Pilar Ruiz-Heredia, Yanira Baumann, Tycho Rodríguez, Antonia Calbacho, María Sánchez, Pilar Martínez Pina, José María Sánchez García-Sancho, Alejandro Martín Figaredo, Gloria Rufián, Laura Rodríguez, Margarita Carneros, Laura Martínez-Laperche, Carolina Bastos-Oreiro, Mariana Wang, Chongwu Cedena, María-Teresa Rapado, Inmaculada de Toledo, Paula Gallardo, Miguel Valeri, Antonio Ayala, Rosa Martínez-López, Joaquín Barrio, Santiago |
| author_facet | Jiménez-Ubieto, Ana Martín-Muñoz, Alejandro Poza, María Dorado, Sara García-Ortiz, Almudena Revilla, Enrique Sarandeses, Pilar Ruiz-Heredia, Yanira Baumann, Tycho Rodríguez, Antonia Calbacho, María Sánchez, Pilar Martínez Pina, José María Sánchez García-Sancho, Alejandro Martín Figaredo, Gloria Rufián, Laura Rodríguez, Margarita Carneros, Laura Martínez-Laperche, Carolina Bastos-Oreiro, Mariana Wang, Chongwu Cedena, María-Teresa Rapado, Inmaculada de Toledo, Paula Gallardo, Miguel Valeri, Antonio Ayala, Rosa Martínez-López, Joaquín Barrio, Santiago |
| author_sort | Jiménez-Ubieto, Ana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10469463 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104694632023-09-01 Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients Jiménez-Ubieto, Ana Martín-Muñoz, Alejandro Poza, María Dorado, Sara García-Ortiz, Almudena Revilla, Enrique Sarandeses, Pilar Ruiz-Heredia, Yanira Baumann, Tycho Rodríguez, Antonia Calbacho, María Sánchez, Pilar Martínez Pina, José María Sánchez García-Sancho, Alejandro Martín Figaredo, Gloria Rufián, Laura Rodríguez, Margarita Carneros, Laura Martínez-Laperche, Carolina Bastos-Oreiro, Mariana Wang, Chongwu Cedena, María-Teresa Rapado, Inmaculada de Toledo, Paula Gallardo, Miguel Valeri, Antonio Ayala, Rosa Martínez-López, Joaquín Barrio, Santiago Front Immunol Immunology Frontiers Media S.A. 2023-08-16 /pmc/articles/PMC10469463/ /pubmed/37662957 http://dx.doi.org/10.3389/fimmu.2023.1243241 Text en Copyright © 2023 Jiménez-Ubieto, Martín-Muñoz, Poza, Dorado, García-Ortiz, Revilla, Sarandeses, Ruiz-Heredia, Baumann, Rodríguez, Calbacho, Sánchez, Pina, García-Sancho, Figaredo, Rufián, Rodríguez, Carneros, Martínez-Laperche, Bastos-Oreiro, Wang, Cedena, Rapado, de Toledo, Gallardo, Valeri, Ayala, Martínez-López and Barrio https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Jiménez-Ubieto, Ana Martín-Muñoz, Alejandro Poza, María Dorado, Sara García-Ortiz, Almudena Revilla, Enrique Sarandeses, Pilar Ruiz-Heredia, Yanira Baumann, Tycho Rodríguez, Antonia Calbacho, María Sánchez, Pilar Martínez Pina, José María Sánchez García-Sancho, Alejandro Martín Figaredo, Gloria Rufián, Laura Rodríguez, Margarita Carneros, Laura Martínez-Laperche, Carolina Bastos-Oreiro, Mariana Wang, Chongwu Cedena, María-Teresa Rapado, Inmaculada de Toledo, Paula Gallardo, Miguel Valeri, Antonio Ayala, Rosa Martínez-López, Joaquín Barrio, Santiago Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients |
| title | Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients |
| title_full | Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients |
| title_fullStr | Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients |
| title_full_unstemmed | Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients |
| title_short | Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients |
| title_sort | corrigendum: personalized monitoring of circulating tumor dna with a specific signature of trackable mutations after chimeric antigen receptor t-cell therapy in follicular lymphoma patients |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469463/ https://www.ncbi.nlm.nih.gov/pubmed/37662957 http://dx.doi.org/10.3389/fimmu.2023.1243241 |
| work_keys_str_mv | AT jimenezubietoana corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT martinmunozalejandro corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT pozamaria corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT doradosara corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT garciaortizalmudena corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT revillaenrique corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT sarandesespilar corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT ruizherediayanira corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT baumanntycho corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT rodriguezantonia corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT calbachomaria corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT sanchezpilarmartinez corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT pinajosemariasanchez corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT garciasanchoalejandromartin corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT figaredogloria corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT rufianlaura corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT rodriguezmargarita corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT carneroslaura corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT martinezlaperchecarolina corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT bastosoreiromariana corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT wangchongwu corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT cedenamariateresa corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT rapadoinmaculada corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT detoledopaula corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT gallardomiguel corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT valeriantonio corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT ayalarosa corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT martinezlopezjoaquin corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients AT barriosantiago corrigendumpersonalizedmonitoringofcirculatingtumordnawithaspecificsignatureoftrackablemutationsafterchimericantigenreceptortcelltherapyinfollicularlymphomapatients |